Model Number PREVUE C (+21.00 D) |
Device Problem
Sharp Edges (4013)
|
Patient Problems
Failure of Implant (1924); Capsular Bag Tear (2639)
|
Event Date 01/03/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
This initial emdr is being submitted to fda as a reportable event that occurred in the usa.Posterior capsule rupture is indicated as a potential adverse event related to iol implantation, as covered under the warnings section of the product's instructions for use (ifu).Manufacturer's codes for: type of investigation, findings, and conclusion are pending device return and completion of product investigation.Once the product investigation is completed, a follow-up report will be submitted to fda which will include the manufacturer's codes for type of investigation, findings, and conclusion.
|
|
Event Description
|
The iol was explanted intraoperatively from the eye due to posterior capsular rupture.There were no issue with the lens or injector.No sutures needed and no incision enlargement anterior vitrectomy was performed.Another iol was implanted to the patient eye.Patient outcome is satisfactory.
|
|
Manufacturer Narrative
|
This follow-up #1 emdr is being submitted to fda for a reportable event that occurred in the usa.Note: delayed emdr submission was due to fda esg webtrader account system software issues, per fda esg help desk ticket # (b)(4) (and subsequent ticket # (b)(4)).Hoya due diligence is documented under internal (b)(4).The report includes corrected information and additional information not available/included in the initial report.The product was returned to the manufacturer.The investigation was conducted, with the methods and results as noted below.Appearance check result was consistent to reported information.No abnormalities were found in production and inspection records of the product.(serial no.: (b)(6); model:prevue c).The exact root cause of the event was not determined.However, based on available information, we believe this event was not caused by our product quality.A review of the most recent complaint trending data indicates that no significant trends have been identified at this time and no capa is required as part of the product evaluation.
|
|
Event Description
|
The iol was explanted intraoperatively from the eye due to posterior capsular rupture.There were no issue with the lens or injector.No sutures needed and no incision enlargement anterior vitrectomy was performed.Another iol was implanted to the patient eye.Patient outcome is satisfactory.
|
|
Search Alerts/Recalls
|